Cargando…
Classical and recent advances in the treatment of inflammatory bowel diseases
Crohn's disease (CD) and ulcerative colitis (UC) are intestinal disorders that comprise the inflammatory bowel diseases (IBD). These disorders have a significant effect on the quality of life of affected patients and the increasing number of IBD cases worldwide is a growing concern. Because of...
Autores principales: | Sales-Campos, H., Basso, P.J., Alves, V.B.F., Fonseca, M.T.C., Bonfá, G., Nardini, V., Cardoso, C.R.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321214/ https://www.ncbi.nlm.nih.gov/pubmed/25466162 http://dx.doi.org/10.1590/1414-431X20143774 |
Ejemplares similares
-
Association among genetic predisposition, gut microbiota, and host immune
response in the etiopathogenesis of inflammatory bowel disease
por: Basso, P.J., et al.
Publicado: (2014) -
Recent advances in inflammatory bowel disease
por: Al Dulaimi, David
Publicado: (2015) -
Recent advances in inflammatory bowel disease
por: Polewiczowska, Beata, et al.
Publicado: (2017) -
Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
por: Basso, Paulo José, et al.
Publicado: (2019) -
Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis
por: Basso, Paulo José, et al.
Publicado: (2021)